Artiva Biotherapeutics, Inc.

ARTV · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
31
SEC Filings

Business Summary

1 Item 1A. Risk Factors 48 Item 1B. Unresolved Staff Comments 117 Item 1C. Cybersecurity 117 Item 2. Properties 119 Item 3. Legal Proceedings 119 Item 4. Mine Safety Disclosures 119 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 120 Item 6. [Reserved] 121 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 122 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 13...

Next Earnings

Q2 FY2026 — expected 2026-08-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionARTVdiscussed_in_filing Cybersecurity
topic_mentionARTVdiscussed_in_filing Cybersecurity
topic_mentionARTVdiscussed_in_filing Cybersecurity
topic_mentionARTVdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001193125-26-100135EDGAR124K words
2025-03-242024-12-310000950170-25-043837EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-275872EDGAR80K words
2025-08-062025-06-300000950170-25-104045EDGAR—
2025-05-082025-03-310000950170-25-066421EDGAR—
2024-11-122024-09-300000950170-24-125382EDGAR—
2024-08-292024-06-300001193125-24-209924EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001193125-26-100131EDGAR2K words
2026-02-240001193125-26-067509EDGAR—
2026-02-190001193125-26-059716EDGAR—
2025-12-120001193125-25-317784EDGAR—
2025-11-120001193125-25-275902EDGAR—
2025-11-120001193125-25-275867EDGAR—
2025-08-060000950170-25-104028EDGAR—
2025-06-250000950170-25-089942EDGAR—
2025-05-080000950170-25-066416EDGAR—
2025-03-240000950170-25-043828EDGAR—

31 total filings indexed. 14 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001817241
TickerARTV
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7e62860bd11be6744636126ce34d72716492beddd4932a311c76211cd06b369f
parent: b1227930aa313bdac84b42816a18e580a72e9ee6a98819b9fe947f91b1e23c13
content hash: 04bc2930fac62c590cb719b1ccb4145fd5b44f76b85451a8c44531e788c49cbb
signed: 2026-04-13T04:43:44.231Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf